Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients

Thrombosis Research

Volumn 125, Issue 4, 2010, Pages

  Nieuwlaat, Robby ^a   Barker, Lucy ^a   Kim, Yang Ki ^a   Haynes, R Brian ^b   Eikelboom, John W ^a   Yusuf, Salim ^a   Connolly, Stuart J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

atrial fibrillation; evidence based medicine; stroke; thrombosis; warfarin

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CANADA; DRUG DOSE REGIMEN; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; MAINTENANCE THERAPY; MEDICAL SPECIALIST; PERSONAL EXPERIENCE; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE;

AMBULATORY CARE FACILITIES; ATRIAL FIBRILLATION; DATA COLLECTION; HUMANS; INTERNATIONAL NORMALIZED RATIO; ONTARIO; PHYSICIANS; PHYSICIANS, FAMILY; QUESTIONNAIRES; SELF CARE; WARFARIN;

EID: 77949655145     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.007     Document Type: Article

References (17)

1. Wolf P.A., Dawber T.R., Thomas Jr. H.E., and Kannel W.B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28 (1978) 973-977
2. Hart R.G., Pearce L.A., and Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (2007) 857-867
3. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
4. Rosendaal F.R., Cannegieter S.C., van der Meer F.J., and Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69 (1993) 236-239
5. Connolly S.J., Pogue J., Eikelboom J., Flaker G., Commerford P., Franzosi M.G., et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 118 (2008) 2029-2037
6. Jones M., McEwan P., Morgan C.L., Peters J.R., Goodfellow J., and Currie C.J. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 91 (2005) 472-477
7. Morgan C.L., McEwan P., Tukiendorf A., Robinson P.A., Clemens A., and Plumb J.M. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res 124 (2009) 37-41
8. White H.D., Gruber M., Feyzi J., Kaatz S., Tse H.F., Husted S., et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167 (2007) 239-245
9. Nieuwlaat R., Eurlings L.W., Capucci A., and Crijns H.J. Atrial fibrillation in the 'real world': undecided issues. Eur Heart J Suppl 9 (2007) I122-I128
10. Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., and Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 160S-198S
11. Garg A.X., Adhikari N.K., McDonald H., Rosas-Arellano M.P., Devereaux P.J., Beyene J., et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 293 (2005) 1223-1238
12. Heneghan C., Alonso-Coello P., Garcia-Alamino J.M., Perera R., Meats E., and Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 367 (2006) 404-411
13. Parry D., Fitzmaurice D., and Raftery J. Anticoagulation management in primary care: a trial-based economic evaluation. Br J Haematol 111 (2000) 530-533
14. Banet G.A., Waterman A.D., Milligan P.E., Gatchel S.K., and Gage B.F. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio. Chest 123 (2003) 499-503
15. Rose A.J., Ozonoff A., Berlowitz D.R., Henault L.E., and Hylek E.M. Warfarin dose management affects INR control. J Thromb Haemost 7 (2009) 94-101
16. van Walraven C., Jennings A., Oake N., Fergusson D., and Forster A.J. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 129 (2006) 1155-1166
17. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.A., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465